Yamada A, Ohi H, Hatano M
Second Department of Internal Medicine, Nihon University, School of Medicine, Tokyo, Japan.
Nihon Jinzo Gakkai Shi. 1990 Apr;32(4):373-8.
C3 nephritic factor (C3 NeF) has been found mainly in the sera of patients with membranoproliferative glomerulonephritis (MPGN) and partial lipodystrophy (PLD). We examined whether peripheral blood mononuclear cells (PBMC) from patients with PLD and MPGN could produce C3 NeF. We investigated the in vitro immunoglobulin synthesis of PBMC with mitogen. We further studied whether or not C3 NeF was included in the IgG of the culture supernatants by the C3bBb stabilizing activity and agglutination assay. The IgG of PLD patient was able to agglutinate only EAC4bBb cells and none of the other intermediate cells. We thus demonstrated that C3 NeF could be produced in vitro by PBMC derived from the patient with PLD. However, as regard case of C3 NeF weakly positive and C3 NeF negative patients, C3 NeF couldn't be produced in vitro by PBMC derived from the patients.
C3 肾炎因子(C3 NeF)主要在膜增生性肾小球肾炎(MPGN)和部分脂肪营养不良(PLD)患者的血清中被发现。我们检测了 PLD 和 MPGN 患者的外周血单个核细胞(PBMC)是否能产生 C3 NeF。我们用有丝分裂原研究了 PBMC 的体外免疫球蛋白合成。我们通过 C3bBb 稳定活性和凝集试验进一步研究培养上清液的 IgG 中是否包含 C3 NeF。PLD 患者的 IgG 仅能凝集 EAC4bBb 细胞,而不能凝集其他任何中间细胞。因此,我们证明 PLD 患者来源的 PBMC 可在体外产生 C3 NeF。然而,对于 C3 NeF 弱阳性和 C3 NeF 阴性的患者,其来源的 PBMC 在体外不能产生 C3 NeF。